Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
Open Access
- 24 November 2014
- journal article
- research article
- Published by Wiley in Tuberculosis Research and Treatment
- Vol. 2014, 1-6
Abstract
Background. Antituberculosis multidrug regimens have been associated with increased incidence of adverse drug reactions (ADRs). This study aimed to determine the incidence and associated factors of ADRs due to antituberculosis therapy.Methods. This is a retrospective cross-sectional study on tuberculosis patients who were treated in tuberculosis clinics in Markazi province in Iran. The information contained in the medical files was extracted and entered into the questionnaire. Data was descriptively analyzed by using statistical package for social sciences (SPSS 18).Results. A total of 940 TB patients of 1240 patients’ medical records available in 10 medical offices were included in this study. Of the 563 ADRs found in this study, 82.4% were considered minor reactions and 17.6% were major reactions. No death from antituberculosis ADR was observed. We found that the risk of major ADRs was higher in females (), age >50 y (), coinfection with HIV (), smoking (), retreatment TB (), and comorbidities ().Conclusions. This study showed that severe side effects of anti-TB drugs are common in patients who have risk factors of ADRs and they should be followed up by close monitoring.
Keywords
Funding Information
- Arak University
This publication has 28 references indexed in Scilit:
- Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in ChinaPLOS ONE, 2011
- Efeitos adversos causados pelo novo esquema de tratamento da tuberculose preconizado pelo Ministério da Saúde do BrasilJornal Brasileiro de Pneumologia, 2010
- Directly observed therapy for treating tuberculosis2007
- Hyperuricemia and Arthralgias During Pyrazinamide Therapy in Patients With Pulmonary TuberculosisLaboratory Medicine, 2007
- Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosisRespiratory Medicine, 2006
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 2003
- Side-effects of antituberculosis drug treatment in patients with chronic renal failureEuropean Respiratory Journal, 2002
- Antituberculosis drug-related liver dysfunction in chronic hepatitis B infectionHepatology, 2000
- Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosisEuropean Respiratory Journal, 1996
- The Role of Pyrazinamide in Tuberculosis ChemotherapyChest, 1988